-
El cáncer de útero es el cáncer más común del aparato reproductor femenino. Se puede formar dentro del recubrimiento interno del útero o en la capa externa del tejido muscular.
-
Se considera que el embarazo molar es resultado de un problema con la información genética transmitida entre un óvulo y un espermatozoide.
-
Aún con la prueba de Papanicolaou y nuevas vacunas para mujeres jóvenes, no hay manera completa de prevenir el cáncer de cuello uterino.
-
El cáncer de vagina representa entre el 2% a 3% de todos los cánceres ginecológicos y es una enfermedad relativamente poco común.
-
Las probabilidades de contraer cáncer de ovarios aumenta con la edad de una mujer. El cáncer de ovarios ocurre en mujeres de más de 50 años de edad y el...
Testimonials
-
Cuando Debbie se enteró que tenía Cáncer de Endometrio, lo único que quería hacer era eliminarlo. Todo lo que quería el Dr. Finkler era que Debbie tuviera el mejor tratamiento...
-
La célebre personalidad televisiva, la Dra. Jan C. Garavaglia, (alias "Dra. G") es la médico forense principal de la Oficina del médico forense del noveno distrito (Orange-...
Investigación de cáncer de vulva
A lot of research is currently underway to find ways to prevent and treat vulvar cancer.
Oncognes and tumor suppressor genes
Scientists have begun to learn more about oncogenes and tumor suppressor genes that control cell growth and turn normal cells into cancerous ones. The goal is to develop a gene therapy that will replace the damaged genes in the cancer cells with normal ones to stop their abnormal behaviors.
HPV vaccines
Currently, Gardisil is the only vaccine approved for use to treat HPV infections. With this initial success, it’s hoped that other vaccines can be developed to treat other types of HPV that can cause female reproductive cancers.
Other vaccines are being investigated to help women who have vulvar cancer (therapeutic vaccines). These vaccines are intended to create an immune reaction in parts of the virus that contribute to the abnormal growth of cells, specifically the E6 and E7 proteins. It’s hoped that this immune reaction will kill the cancer cells or stop them from growing more.
Combined therapies
Finally, researchers are looking at the most effective ways to combine surgery, radiation therapy and chemotherapy to combat vulvar cancer. Clinical trials are investigating how radiation after surgery can contribute to the killing of cancer cells. Other trials are studying the effectiveness of chemotherapy or pelvic radiation therapy to treat cancer that has spread to the lymph nodes.
Clinical trials are underway on a number of fronts. Currently, the National Cancer Institute lists nearly 50 trials being conducted for vulvar cancer and the Gynecologic Oncology Center offers patients one of the widest ranges of clinical trial options in the nation. Many of these promising treatments won’t be available to the general public for months, if not years, to come.
For a complete list, click here.